SPHK2 and lung carcinoma: However, an effective use of FTY720 for cancer therapy would be to combine it with a SPHK2 inhibitor in order to prevent the synthesis of p-FTY720, which does not seem to play a role in chronic myeloid leukemia or lung cancer cell deaths [184,188] and also causes immune suppression [8].